25 OUR PURPOSE PIONEERING SCIENCE PATIENTS OUR PEOPLE ENVIRONMENT COMMUNITY REPORTING expertise to the production of small molecule therapies and have fully integrated an oral solid dose facility into our manufacturing infrastructure.